Yakira Capital Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Yakira Capital Management’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-144,826	Closed	-$2.38M	–	363
2023 Q4	$2.38M	Buy	+144,826	New	+$2.28M	0.78%	44

Yakira Capital Management's ORTX Position: Q1 2024 in Review

Yakira Capital Management sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2024, closing a stake of 144,826 shares — an estimated $2.38M sold.

Yakira Capital Management first reported a position in ORTX in Q4 2023 and held it in 1 quarter. The position peaked at $2.38M in Q4 2023. 0 funds tracked by Wall St. Rank hold ORTX as of Q1 2024.

Yakira Capital Management reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Yakira Capital Management sold 144,826 Orchard Therapeutics plc American Depositary Shares shares in Q1 2024, an estimated $2.38M.
Yakira Capital Management first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2023 and held it in 1 quarter.
Yakira Capital Management's Orchard Therapeutics plc American Depositary Shares position peaked at $2.38M in Q4 2023.
0 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2024.

Based on Yakira Capital Management's 13F filing for Q1 2024, filed 14 May 2024.